Obesity is associated with a more severe overactive bladder disease state that is effectively treated with once‐daily administration of trospium chloride extended release
- 24 July 2009
- journal article
- research article
- Published by Wiley in Neurourology and Urodynamics
- Vol. 29 (4) , 551-554
Abstract
Aims: Obesity is an established risk factor for urinary incontinence, yet no information exists as to the efficacy of antimuscarinic agents in this population. The goal of this study is to examine the efficacy of once daily trospium chloride (Sanctura™) XR in overweight and obese patients with the overactive bladder syndrome.Methods: The primary and secondary end‐points of the 1,165 study subjects from the integrated trospium chloride XR pivotal trials were stratified by World Health Organization (WHO) obesity levels I and II.Results: Obesity (WHO level I, II criteria) was associated with a more severe baseline OAB disease state (P < 0.01). Trospium chloride XR was more effective than placebo at reducing the primary endpoints (toilet voids, UUI, P < 0.0001) and at improving the secondary end‐points (percent patients continent and urgency severity, P < 0.0001) for WHO obesity levels I and II.Conclusions: Obesity is associated with a more severe OAB disease state. Once daily trospium chloride XR is efficacious in the obese patient with the OAB syndrome. Neurourol. Urodynam. 29:551–554, 2010.Keywords
This publication has 19 references indexed in Scilit:
- EXPRESSION OF GHRELIN RECEPTOR IN BLADDER POINTS TO A NEW LINK BETWEEN OBESITY AND THE OVERACTIVE BLADDERJournal of Urology, 2009
- Weight Loss to Treat Urinary Incontinence in Overweight and Obese WomenNew England Journal of Medicine, 2009
- A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in womenNeurourology and Urodynamics, 2008
- Urodynamic characterization of obese women with urinary incontinence undergoing a weight loss program: the Program to Reduce Incontinence by Diet and Exercise (PRIDE) trialInternational Urogynecology Journal, 2008
- Once Daily Trospium Chloride is Effective and Well Tolerated for the Treatment of Overactive Bladder: Results From a Multicenter Phase III TrialJournal of Urology, 2007
- A VALIDATED PATIENT REPORTED MEASURE OF URINARY URGENCY SEVERITY IN OVERACTIVE BLADDER FOR USE IN CLINICAL TRIALSJournal of Urology, 2005
- Clinical Pharmacokinetics of Trospium ChlorideClinical Pharmacokinetics, 2005
- The association of diet and other lifestyle factors with the onset of overactive bladder: a longitudinal study in menPublic Health Nutrition, 2004
- The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in womenBJU International, 2003
- Urinary incontinence in older women: Who is at risk?Obstetrics & Gynecology, 1996